Health
Latest Content
UK’s first AI-driven Level 3 lab launches first commercial project
A joint British-Canadian initiative for infectious disease vaccines will be the first commercial project to be carried out in the new Liverpool Robotic Infection Research Laboratory.
News
UK’s first AI-driven Level 3 lab launches first commercial project
A joint British-Canadian initiative for infectious disease vaccines will be the first commercial project to be carried out in the new Liverpool Robotic Infection Research Laboratory.
In Depth
Knowledge is power: In silico modelling of Covid-19
Scientific research takes time. But, as the Covid-19 pandemic highlighted, sometimes that’s a luxury scientists can’t afford, says ≈. Experimentation and data guide us to the ‘right’ decision based o…
Comment And Analysis
Protein integrity in the cause of science
The IMPALA-NET network is developing a polymer-lipid particle technique to preserve the lipid environment of cell membrane proteins with the aim of improving drug discovery and testing for a wide ran…
Interviews
Global focus: the key to infectious disease control
President of the International Society for Infectious Diseases, Professor Paul Ananth Tambyah explains to Rachel Sully the importance of recognising, declaring and responding to infectious diseases s…
